Cannabis News
US (MD): New CULTA CEO announced
CULTA has appointed Joseph Andreae as CEO.
“Having grown up in the greater DMV area and spent a lot of time in Maryland, I know firsthand how unique this state is, and that includes its cannabis industry,” said Joseph Andreae. “CULTA truly represents that and the dedicated Marylanders who keep the engine running day in and day out, and I look forward to the opportunity to further shape this brand and solidify our position as a leader in this growing Eastern market.”
Joseph brings a wealth of experience from mature cannabis programs across the country, along with a specific appreciation of the Maryland market. Prior to joining CULTA, he held leadership roles at a number of large scale, vertically integrated cannabis companies including Story Cannabis, Glass House Brands and NorCal Cannabis Company.
© CULT
In this new role, Joseph will prioritize building an experienced leadership team with deep knowledge of the legal industry and local community, leveraging CULTA’s infrastructure to improve product development and quality, maintaining a strong firm culture and brand identity, and differentiating from competitors through fresh firm values that prioritize investment in its employees and clients. increasing the perception and benefits of cannabis.
For more information:
Cult
www.culta.io
Tilray Medical has announced the launch of its first medical cannabis product in Panama, part of the company’s continued global expansion and commitment to improving patient access to pharmaceutical grade cannabinoids worldwide.
Following the successful shipment of Tilray Oral Solution CBD100 from Tilray Medical’s EU-GMP certified production facilities in Portugal through a joint venture with Solana Life Group S. de RL, the Product is to be distributed through Farmacias Arrocha, one of the leading pharmaceutical chains in Panama, where patients will be able to access Tilray Oral Solution CBD with medical prescription100. This is expected to provide patients and healthcare professionals with access to regulated medical cannabis of pharmaceutical quality through established healthcare channels.
Rajnish Ohri, International President, Tilray Brands, said: “At Tilray Medical, we believe that every patient deserves access to safe, consistent, pharmaceutical-grade cannabis products. The launch in Panama reflects our broader vision to expand access to cannabinoid-based medicines around the world. We want pharmacists and patients to help shape the future of responsible access, advance medical education and provide high-quality treatment options that improve lives.”
The launch supports the Panamanian medical cannabis framework established by Law 242 of 2021 and follows important regulatory advances made by the Ministry of Health, including No. 0406 of May 12, 2026. The decision, which established the main conditions for the admission of patients. The Ministry also recently introduced the System for the Identification of Medical Cannabis Users and Authorized Caregivers (SIUCMAA), creating a structured way to authorize medical practitioners and register patients.
Manufactured in Portugal under strict European Union Good Manufacturing Practice (EU-GMP) standards, Tilray Oral Solution CBD100 is intended for use in patients with qualified medical conditions permitted under Panamanian law, where permitted. The products reflect Tilray Medical’s longstanding commitment to pharmaceutical quality, product consistency, patient safety and regulatory compliance.
Tilray Medical’s advanced cultivation and manufacturing facilities in Portugal serve as a strategic global export hub, supplying EU-GMP certified medical cannabis products to regulated markets worldwide. The platform enables Tilray Medical to effectively support growing international demand while maintaining the highest pharmaceutical manufacturing standards across its global operations.
For more information:
Tilray
www.tilray.com
Cannabis News
Medical Marijuana Is ‘Effective’ In Providing Relief To Patients With Restless Legs Syndrome, Study Shows
Wyoming Attorney General Keith Kautz announced on July 7 that he would keep all marijuana products in Schedule I of Wyoming’s Controlled Substances Act, refusing to align the state’s cannabis policy with the federal reorganization order issued earlier this year.
Kautz, who also serves as Wyoming’s drug and substance abuse commissioner, held a public hearing on June 18 after filing an objection to aligning the state’s cannabis schedule with a federal amendment on May 27. State law requires the commissioner to give interested parties an opportunity to be heard after that objection, but only nine people responded. Four email comments supported leaving cannabis as a Schedule I drug, four as Schedule III. It was approved for use and one person attended the hearing to request that cannabis remain in Schedule I.
His decision follows an April 2026 order signed by U.S. Attorney General Todd Blanche that bans state-licensed medical cannabis, FDA-approved cannabis products, cannabis extracts and naturally derived delta-9 THC III.
Kautz’s office says: “After consideration of all stakeholder comments, the commissioner has determined that all marijuana products, including marijuana subject to the state’s medical marijuana license, will remain in Schedule I of the Wyoming Controlled Substances Act.”
His announcement adds, “The decision to reschedule medical marijuana and marijuana products is an important policy decision that is best left to the Wyoming Legislature and should not be made through administrative rule.”
Wyoming remains one of eight states without a medical cannabis program. A December 2020 poll by the University of Wyoming’s Wyoming Center for Polling and Analysis found that 85 percent of state residents support legalizing medical cannabis, despite a failed 2024 ballot initiative effort. Possession of three ounces or less carries up to 12 months in prison under current state law, and selling any amount is punishable by up to 10 years in prison and a $10,000 fine.
Kautz says his office will “properly schedule products approved by the United States Food and Drug Administration once that agency has approved the product,” pointing to the Schedules II and III listings of Cesamet and Dronabinol as evidence that the state complies with federal cannabinoid drug law.
Legalization is the goal, Is Sked. 3 the way to get there? The B Block of Weed Talk News 5/14/24
FREE CANNABIS JOB TRAINING | ADRIANA HERRERA
Marijuana Retail Report
Tilray Medical announces commercial launch of medical cannabis in Panama
States Keep Moving While Washington Waits
Medical Marijuana Is ‘Effective’ In Providing Relief To Patients With Restless Legs Syndrome, Study Shows
California Authorities Seize 63,000 Pounds of Unregulated Cannabis in Three Months
Weed Talk News the C Block 5-15-24 Re ports from Texas, Missouri, Ohio, Nevada, Oregon and Wash. st.
HOPE & HEALING with CANNABIS | DR JOSEPH ROSADO
Marijuana Retail Report
“Our system can manage equipment across 10,000+ m² using just a few wires”
Florida Workshop to Discuss What Constitutes a ‘Cartoon’ in Hemp Packaging
Mazar-i-Sharif Hash Wednesday
Afghan Black Hash Wednesday
Weak Michigan Cannabis Sales Again in July – New Cannabis Ventures
From Finance to Wellness: Brad Zerman’s Impactful Pivot
Re-release of the full show of Cannabis Coast to Coast news. Republican Texas DA Fires Up vs. laws;
DEA’s Cole Reverses His “priorities” ; Prohibitionists Dig In; Dead & Co Celebrates 60 years in SF
Curaleaf Q2 Revenue Falls 8% – New Cannabis Ventures
Texas DA Fires Up for Change! Mass. Sheriff arrested on Extortion charges; GOP vs Industry in state
-
Cannabis News11 months ago“Our system can manage equipment across 10,000+ m² using just a few wires”
-
Florida11 months agoFlorida Workshop to Discuss What Constitutes a ‘Cartoon’ in Hemp Packaging
-
Video9 months agoMazar-i-Sharif Hash Wednesday
-
Video9 months agoAfghan Black Hash Wednesday
-
aawh11 months agoWeak Michigan Cannabis Sales Again in July – New Cannabis Ventures
-
Video11 months agoFrom Finance to Wellness: Brad Zerman’s Impactful Pivot
-
Video11 months agoRe-release of the full show of Cannabis Coast to Coast news. Republican Texas DA Fires Up vs. laws;
-
Video11 months agoDEA’s Cole Reverses His “priorities” ; Prohibitionists Dig In; Dead & Co Celebrates 60 years in SF